Description

This vial contains 5mg of AOD 9604, a synthetic peptide fragment corresponding to amino acids 177-191 of the C-terminus of Human Growth Hormone (HGH), with a tyrosine added at the N-terminus. This peptide is frequently utilized in research settings to investigate lipid metabolism and cartilage repair mechanisms without the insulin-like effects of the full HGH molecule.

Chemical Profile

This product is a high-purity (>99%), lyophilized (freeze-dried) powder requiring reconstitution. It is intended for laboratory handling and experimental analysis only.

• Component: AOD 9604 (Tyr-hGH Frag 177-191)

• Total Quantity: [5mg]

• Purity: >99% (Determined by HPLC)

Quality Assurance

• HPLC Analysis: Validated >99% purity.

• Mass Spectrometry: Confirmed molecular weight and structure.

• Toxicity: Not tested for human safety.

Research Context (Literature Review)

Note: The following is for educational purposes regarding the chemical properties of these peptides and does not constitute a medical claim.

AOD 9604 acts as a lipolytic agent in research models. In-vitro studies have observed its ability to stimulate the breakdown of fat (lipolysis) and inhibit the transformation of non-fat food materials into body fat (lipogenesis). Unlike the full Growth Hormone molecule, AOD 9604 has not been observed to bind to the GH receptor, meaning it does not induce IGF-1 secretion or alter insulin sensitivity in laboratory subjects.

Recent research has also explored AOD 9604’s potential role in regenerative medicine. Studies in animal models suggest it may enhance the production of collagen and proteoglycans, potentially aiding in the repair of cartilage and connective tissue.

Technical Specifications